BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang D, Zhang B, Lv JT, Sa RN, Zhang XM, Lin ZJ. The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence. Pharmacol Res 2020;157:104882. [PMID: 32380051 DOI: 10.1016/j.phrs.2020.104882] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Rahman MM, Islam MR, Akash S, Mim SA, Rahaman MS, Emran TB, Akkol EK, Sharma R, Alhumaydhi FA, Sweilam SH, Hossain ME, Ray TK, Sultana S, Ahmed M, Sobarzo-sánchez E, Wilairatana P. In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective. Front Cell Infect Microbiol 2022;12:929430. [DOI: 10.3389/fcimb.2022.929430] [Reference Citation Analysis]
2 Li L, Xie H, Wang L, Zhang A, Mou X, Lin Y, Ma H, Wang Y, Li J, Gao J, Wang CC, Leung PC, Fan X, Wu X. The efficacy and safety of combined chinese herbal medicine and western medicine therapy for COVID-19: a systematic review and meta-analysis. Chin Med 2022;17:77. [PMID: 35729581 DOI: 10.1186/s13020-022-00600-z] [Reference Citation Analysis]
3 Yao Q, Zhu X, Han M, Chen C, Li W, Bai H, Ning K. Decoding herbal materials of TCM preparations with the multi-barcode sequencing approach. Sci Rep 2022;12:5988. [PMID: 35397643 DOI: 10.1038/s41598-022-09979-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ma Q, Lei B, Chen R, Liu B, Lu W, Jiang H, Chen Z, Guo X, Wang Y, Zhang L, Chen Q, Li X, Yang Z. Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro. Chin Med 2022;17:40. [PMID: 35365215 DOI: 10.1186/s13020-022-00598-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Luo W, Ding R, Guo X, Zhan T, Tang T, Fan R, Wang Y. Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID-19 by dual binding to IL-6/STAT3. Comput Biol Med 2022;145:105457. [PMID: 35366469 DOI: 10.1016/j.compbiomed.2022.105457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nazar N, Howard C, Slater A, Sgamma T. Challenges in Medicinal and Aromatic Plants DNA Barcoding-Lessons from the Lamiaceae. Plants (Basel) 2022;11:137. [PMID: 35009140 DOI: 10.3390/plants11010137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Shi K, Liu Y, Zhang Q, Ran CP, Hou J, Zhang Y, Wang XB. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment. Chin J Integr Med 2022;28:3-11. [PMID: 34962616 DOI: 10.1007/s11655-021-3313-x] [Reference Citation Analysis]
8 Li J, Huang Z, Lu S, Luo H, Tan Y, Ye P, Liu X, Wu Z, Wu C, Stalin A, Wang H, Liu Y, Shen L, Fan X, Zhang B, Yi J, Yao L, Xu Y, Wu J, Duan X. Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking. Medicine (Baltimore) 2021;100:e27112. [PMID: 34941025 DOI: 10.1097/MD.0000000000027112] [Reference Citation Analysis]
9 Xiang MF, Jin CT, Sun LH, Zhang ZH, Yao JJ, Li LC. Efficacy and potential mechanisms of Chinese herbal compounds in coronavirus disease 2019: advances of laboratory and clinical studies. Chin Med 2021;16:130. [PMID: 34861881 DOI: 10.1186/s13020-021-00542-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Chapman RL, Andurkar SV. A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19. Med Chem Res 2021;:1-12. [PMID: 34873386 DOI: 10.1007/s00044-021-02826-2] [Reference Citation Analysis]
11 Saha P, Bose S, Srivastava AK, Chaudhary AA, Lall R, Prasad S. Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions. Molecules 2021;26:6783. [PMID: 34833873 DOI: 10.3390/molecules26226783] [Reference Citation Analysis]
12 Wang DC, Yu M, Xie WX, Huang LY, Wei J, Lei YH. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019. J Integr Med 2021:S2095-4964(21)00100-X. [PMID: 34782291 DOI: 10.1016/j.joim.2021.10.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lyu M, Fan G, Xiao G, Wang T, Xu D, Gao J, Ge S, Li Q, Ma Y, Zhang H, Wang J, Cui Y, Zhang J, Zhu Y, Zhang B. Traditional Chinese medicine in COVID-19. Acta Pharm Sin B 2021;11:3337-63. [PMID: 34567957 DOI: 10.1016/j.apsb.2021.09.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
14 Tagde P, Tagde S, Tagde P, Bhattacharya T, Monzur SM, Rahman MH, Otrisal P, Behl T, Ul Hassan SS, Abdel-Daim MM, Aleya L, Bungau S. Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2. Biomedicines 2021;9:1266. [PMID: 34572452 DOI: 10.3390/biomedicines9091266] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
15 Chu L, Huang F, Zhang M, Huang B, Wang Y. Current status of traditional Chinese medicine for the treatment of COVID-19 in China. Chin Med 2021;16:63. [PMID: 34315521 DOI: 10.1186/s13020-021-00461-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
16 Yang ZH, Wang B, Ma Q, Wang L, Lin YX, Yan HF, Fan ZX, Chen HJ, Ge Z, Zhu F, Wang HJ, Zhang BN, Sun HD, Feng LM. Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review. Front Pharmacol 2021;12:668407. [PMID: 34335247 DOI: 10.3389/fphar.2021.668407] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
17 Cui X, Chen W, Zhou H, Gong Y, Zhu B, Lv X, Guo H, Duan J, Zhou J, Marcon E, Ma H. Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential. Front Pharmacol 2021;12:664349. [PMID: 34163357 DOI: 10.3389/fphar.2021.664349] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
18 Liang SB, Fang M, Liang CH, Lan HD, Shen C, Yan LJ, Hu XY, Han M, Robinson N, Liu JP. Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 2021;60:102744. [PMID: 34091029 DOI: 10.1016/j.ctim.2021.102744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zuo HL, Lin YC, Huang HY, Wang X, Tang Y, Hu YJ, Kong XJ, Chen QJ, Zhang YZ, Hong HC, Li J, Hu SY, Huang HD. The challenges and opportunities of traditional Chinese medicines against COVID-19: a way out from a network perspective. Acta Pharmacol Sin 2021;42:845-7. [PMID: 33850275 DOI: 10.1038/s41401-021-00645-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
20 Wen J, Wang CC, Goh E, Su Z, Ying T. Traditional Chinese medicine as a tourism recovery drawcard to boost China's inbound tourism after COVID-19. APJML 2021;34:385-400. [DOI: 10.1108/apjml-10-2020-0732] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Van Tat P, Hoa TT, Vo Ky A, Nu Ngoc Han P. NOVEL SARS-CoV-2 INHIBITORS FROM PHENETHYLTHIAZOLETHIOUREA DERIVATIVES USING HYBRID QSAR MODELS AND DOCKING SIMULATION. Smart Science 2021;9:165-85. [DOI: 10.1080/23080477.2021.1914967] [Reference Citation Analysis]
22 Guha S, Chakraborty A. Coronavirus management and control: Nutrition and alternative medicines. Nutr Health 2021;:2601060211009704. [PMID: 33858237 DOI: 10.1177/02601060211009704] [Reference Citation Analysis]
23 Zhang Q, Yue S, Wang W, Chen Y, Zhao C, Song Y, Yan D, Zhang L, Tang Y. Potential Role of Gut Microbiota in Traditional Chinese Medicine against COVID-19. Am J Chin Med 2021;49:785-803. [PMID: 33853498 DOI: 10.1142/S0192415X21500373] [Reference Citation Analysis]
24 Wu Z, Chen X, Ni W, Zhou D, Chai S, Ye W, Zhang Z, Guo Y, Ren L, Zeng Y. The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study. RSC Adv 2021;11:11821-43. [PMID: 35423770 DOI: 10.1039/d0ra07035a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 Li Y, Zhang J, Li S, Li F, Zhao C, Li F, Wang W, Wang W. Efficacy and safety of Reyanning mixture combined with conventional Western medicine for treating COVID-19: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24169. [PMID: 33546032 DOI: 10.1097/MD.0000000000024169] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Du A, Zheng R, Disoma C, Li S, Chen Z, Li S, Liu P, Zhou Y, Shen Y, Liu S, Zhang Y, Dong Z, Yang Q, Alsaadawe M, Razzaq A, Peng Y, Chen X, Hu L, Peng J, Zhang Q, Jiang T, Mo L, Li S, Xia Z. Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2. Int J Biol Macromol 2021;176:1-12. [PMID: 33548314 DOI: 10.1016/j.ijbiomac.2021.02.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
27 Jia S, Luo H, Liu X, Fan X, Huang Z, Lu S, Shen L, Guo S, Liu Y, Wang Z, Cao L, Cao Z, Zhang X, Zhou W, Zhang J, Li J, Wu J, Xiao W. Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification. J Ethnopharmacol 2021;273:113871. [PMID: 33485971 DOI: 10.1016/j.jep.2021.113871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 An YW, Yuan B, Wang JC, Wang C, Liu TT, Song S, Liu HQ. Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19. Int J Med Sci. 2021;18:646-651. [PMID: 33437199 DOI: 10.7150/ijms.52664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
29 Ji F, Wang L, Li C, Wang L, Hao J, Dai M, Liu Y, Pan X, Fu J, Li L, Yang G, Yang J, Zhang X, Wang J, Wang R, Yan X, Gu B. Clinical findings in a group of COVID-19 patients: a single-center retrospective study. Ann Transl Med 2021;9:44. [PMID: 33553337 DOI: 10.21037/atm-20-3333] [Reference Citation Analysis]
30 Zhang N, Shi N, Li S, Liu G, Han Y, Liu L, Zhang X, Kong X, Zhang B, Yuan W, Liu Y, Deng D, Zheng M, Zhang Y, Li L, Wang X, Wu J, Lin X, Nian H, Wu X, Wang H, Liu F, Wang H, Wang H, Liu Y, Liu L, Zeng W, Yang M, Wang Y, Zhai H, Wang Y. A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China. Front Pharmacol 2020;11:574562. [PMID: 33776751 DOI: 10.3389/fphar.2020.574562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
31 Fan Q, Guo L, Guan J, Chen J, Fan Y, Chen Z, Li H. Network Pharmacology-Based Study on the Mechanism of Gegen Qinlian Decoction against Colorectal Cancer. Evid Based Complement Alternat Med 2020;2020:8897879. [PMID: 33294000 DOI: 10.1155/2020/8897879] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Cao C, Zhen Z, Kuang S, Xu T. Reduning injection combined with western medicine for pneumonia: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22757. [PMID: 33120780 DOI: 10.1097/MD.0000000000022757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Zhang Y, Chen Y, Meng Z. Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.Front Immunol. 2020;11:577442. [PMID: 33240265 DOI: 10.3389/fimmu.2020.577442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
34 Xiong H, Dong Z, Lou G, Gan Q, Wang J, Huang Q. Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools. Eur J Integr Med 2020;40:101241. [PMID: 33520015 DOI: 10.1016/j.eujim.2020.101241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Dube T, Ghosh A, Mishra J, Kompella UB, Panda JJ. Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector. Adv Ther (Weinh) 2020;:2000172. [PMID: 33173808 DOI: 10.1002/adtp.202000172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
36 Huang J, Tao G, Liu J, Cai J, Huang Z, Chen JX. Current Prevention of COVID-19: Natural Products and Herbal Medicine. Front Pharmacol 2020;11:588508. [PMID: 33178026 DOI: 10.3389/fphar.2020.588508] [Cited by in Crossref: 23] [Cited by in F6Publishing: 53] [Article Influence: 11.5] [Reference Citation Analysis]
37 Larenas-Linnemann D, Rodríguez-Pérez N, Arias-Cruz A, Blandón-Vijil MV, Del Río-Navarro BE, Estrada-Cardona A, Gereda JE, Luna-Pech JA, Navarrete-Rodríguez EM, Onuma-Takane E, Pozo-Beltrán CF, Rojo-Gutiérrez MI. Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions. World Allergy Organ J 2020;13:100476. [PMID: 33072240 DOI: 10.1016/j.waojou.2020.100476] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
38 Zhang J, Li S, Zhao C, Wang W, Li F, Li F. The therapeutic efficacy of Chinese patent medicine combined with routine western medicine in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22277. [PMID: 32957380 DOI: 10.1097/MD.0000000000022277] [Reference Citation Analysis]
39 Peng W, Xu Y, Han D, Feng F, Wang Z, Gu C, Zhou X, Wu Q. Potential mechanism underlying the effect of matrine on COVID-19 patients revealed through network pharmacological approaches and molecular docking analysis. Arch Physiol Biochem 2020;:1-8. [PMID: 32915649 DOI: 10.1080/13813455.2020.1817944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
40 Xie R, Xia Y, Chen Y, Li H, Shang H, Kuang X, Xia L, Guo Y. The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation. Pharmacol Res 2020;160:105178. [PMID: 32889127 DOI: 10.1016/j.phrs.2020.105178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
41 Leung EL, Pan HD, Huang YF, Fan XX, Wang WY, He F, Cai J, Zhou H, Liu L. The Scientific Foundation of Chinese Herbal Medicine against COVID-19. Engineering (Beijing) 2020;6:1099-107. [PMID: 33520331 DOI: 10.1016/j.eng.2020.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Pang W, Zhang D, Zhang J, Li N, Zheng W, Wang H, Liu C, Yang F, Pang B. Tongue features of patients with coronavirus disease 2019: a retrospective cross-sectional study. Integr Med Res 2020;9:100493. [PMID: 32817820 DOI: 10.1016/j.imr.2020.100493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
43 Shi YH, Huang YF, Wang WY, Yang L, Zhou H, Sang Z. Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment. Pharmacol Res 2020;160:105074. [PMID: 32653649 DOI: 10.1016/j.phrs.2020.105074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
44 Xiong X, Wang P, Su K, Cho WC, Xing Y. Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis. Pharmacol Res 2020;160:105056. [PMID: 32622723 DOI: 10.1016/j.phrs.2020.105056] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 17.0] [Reference Citation Analysis]
45 Kong Q, Wu Y, Gu Y, Lv Q, Qi F, Gong S, Chen X. Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools. Biomed Pharmacother 2020;128:110316. [PMID: 32505821 DOI: 10.1016/j.biopha.2020.110316] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
46 Weng JK. Plant Solutions for the COVID-19 Pandemic and Beyond: Historical Reflections and Future Perspectives. Mol Plant 2020;13:803-7. [PMID: 32442649 DOI: 10.1016/j.molp.2020.05.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]